Drug information for NEOMYCIN SULFATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 500MG Prescription AA (Reference Drug) NEOMYCIN SULFATE Neomycin TEVA 60304
TABLET; ORAL 500MG Discontinued   NEOMYCIN SULFATE Neomycin BRISTOL MYERS SQUIBB 60365
TABLET; ORAL 500MG Discontinued   NEOMYCIN SULFATE Neomycin LILLY 60385
TABLET; ORAL 500MG Discontinued   NEOMYCIN SULFATE Neomycin LANNETT 60607
TABLET; ORAL 500MG Discontinued   NEOMYCIN SULFATE Neomycin SANDOZ 61586
TABLET; ORAL 500MG Discontinued   NEOMYCIN SULFATE Neomycin ROXANE 62173
TABLET; ORAL 500MG Prescription AA  NEOMYCIN SULFATE Neomycin X GEN PHARMS 65220
TABLET; ORAL 500MG Prescription AA  NEOMYCIN SULFATE Neomycin OMAN PHARM PRODUCTS 65468

Drug Adverse Effects information for NEOMYCIN SULFATE

Role code Indications Reaction # Reports
PS GLAUCOMA ANAPHYLACTIC REACTION 1
PS GLAUCOMA ERYTHEMA 1
PS GLAUCOMA THROAT IRRITATION 1
PS GLAUCOMA URTICARIA 1
PS SKIN LESION ANAPHYLACTIC REACTION 1
PS SKIN LESION ERYTHEMA 1
PS SKIN LESION THROAT IRRITATION 1
PS SKIN LESION URTICARIA 1
SS CHRONIC LYMPHOCYTIC LEUKAEMIA GRAFT VERSUS HOST DISEASE 1
SS CHRONIC LYMPHOCYTIC LEUKAEMIA PNEUMONIA FUNGAL 1
SS CHRONIC LYMPHOCYTIC LEUKAEMIA STEM CELL TRANSPLANT 1
C AGE-RELATED MACULAR DEGENERATION CONJUNCTIVITIS 2
C AGE-RELATED MACULAR DEGENERATION CONJUNCTIVITIS ALLERGIC 2
C AGE-RELATED MACULAR DEGENERATION DRY EYE 2
C AGE-RELATED MACULAR DEGENERATION INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
C AGE-RELATED MACULAR DEGENERATION IRIDOCYCLITIS 2
C AGE-RELATED MACULAR DEGENERATION OCULAR HYPERAEMIA 2
C AGE-RELATED MACULAR DEGENERATION UVEITIS 2
C PRODUCT USED FOR UNKNOWN INDICATION CONJUNCTIVITIS 14
C PRODUCT USED FOR UNKNOWN INDICATION CONJUNCTIVITIS ALLERGIC 14
C PRODUCT USED FOR UNKNOWN INDICATION DRY EYE 14
C PRODUCT USED FOR UNKNOWN INDICATION INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14
C PRODUCT USED FOR UNKNOWN INDICATION IRIDOCYCLITIS 14
C PRODUCT USED FOR UNKNOWN INDICATION OCULAR HYPERAEMIA 14
C PRODUCT USED FOR UNKNOWN INDICATION UVEITIS 14
Ads by Google